Heterocyclic amides and the use thereof in the treatment of thromboembolic diseases and tumors
CA 2501706 A1 · Owner: Gleitz, Johannes · Inventors: Cezanne, Bertram; Tsaklakidis, Christos; Mederski, Werner
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to novel compounds of formula (I) wherein D, W, X, Y, T , and R1 have the meanings as cited in Patent Claim 1. These compounds are inhibitors of coagulation factor Xa and can be used for the prevention and/or treatment of thromboembolic diseases and for treating tumors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 18, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 18, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 18, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.